Comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 vs 3m Syndrome 3 C3280146
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetal Androgens Excess and 3M Syndrome 3 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
A condition where an XX fetus produces excess male hormones, often from adrenal gland abnormalities, leading to atypical genital development. It is identified at birth. Treatment typically includes hormone therapy and possible surgery.
3m Syndrome 3 C3280146
A genetic condition causing intrauterine growth restriction and postnatal short stature with distinctive facial features. Treatment focuses on growth monitoring and supportive measures.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
0-0
3m Syndrome 3 C3280146
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
severe
3m Syndrome 3 C3280146
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
Chronic
3m Syndrome 3 C3280146
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
No
3m Syndrome 3 C3280146
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
reproductive
3m Syndrome 3 C3280146
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
endocrine
3m Syndrome 3 C3280146
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetal-androgens-excess-C5680189 and 3m-syndrome-3-C3280146 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3m Syndrome 3 C3280146 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may be recognized at birth in an XX fetus. | Genital atypicality is not described as a defining feature. | High |
| Growth pattern | Intrauterine growth restriction and postnatal short stature are not established by the source. | Intrauterine growth restriction and postnatal short stature are characteristic. | High |
| Facial appearance | Distinctive facial features are not part of the supplied description. | Distinctive facial features are described. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 when
Newborn with atypical genitalia and suspected androgen exposure
The source centers on fetal androgen excess and adrenal abnormalities.
Moderate
Endocrine evaluation of a 46,XX infant
The category is endocrine and the body system is reproductive.
Moderate
Need to distinguish a test finding from a diagnosis
Karyotype or hormone results alone do not establish the full diagnosis.
High
Choose 3m Syndrome 3 C3280146 when
Prenatal or postnatal growth restriction with short stature
Growth impairment is the central described feature.
Moderate
Musculoskeletal genetic syndrome suspected
The source assigns a genetic category and musculoskeletal system.
Moderate
Supportive growth monitoring is the main need
Described management emphasizes monitoring and supportive measures.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3m Syndrome 3 C3280146 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is implied by the concept name; confirmation is clinical. | No specific karyotype pattern is supplied. | A karyotype supports classification but does not prove androgen excess. |
| Endocrine assessment | Androgen excess, often related to adrenal abnormality, may be investigated. | No characteristic endocrine abnormality is supplied. | Abnormal hormone results are findings, not a complete diagnosis. |
| Growth and genetic evaluation | Growth restriction is not established here. | Growth monitoring is central; a specific genetic test result is not supplied. | Genetic confirmation and subtype assignment require specialist interpretation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
- Outcome
- Long-term outcome is not established in the supplied data.
- Factors
- Reported contributors include androgen source, genital development, and endocrine care; exact effects are unknown.
3m Syndrome 3 C3280146
- Outcome
- Outcome is not quantified; growth monitoring and support are emphasized.
- Factors
- Growth pattern and genetic confirmation may matter, but their effect is not established here.
Time frame: Both are described as congenital and chronic; precise timelines are unavailable.
Severity labels differ, but prognosis cannot be ranked from these sources.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental concerns | Atypical genital development is described; exact complications are not established. Short stature and facial features are described; complication rates are not supplied. Do not infer specific morbidity from these sparse descriptions. |
| Endocrine burden | Hormone therapy is typically mentioned, without doses or outcomes. No hormone-specific complication is established. Treatment decisions belong to clinicians. |
| Long-term course | Described as chronic and severe, but prognosis data are absent. Described as chronic and moderate, without mortality data. Severity labels are source classifications, not measured outcomes. |
Patient education highlights
- HighSpecialist care
Both conditions need individualized specialist assessment; do not rely on labels alone.
- MediumWhat the finding means
An abnormal genital, growth, hormone, or genetic finding is not automatically a final diagnosis.
- LowSupport
Ask about monitoring, psychosocial support, and which tests are still needed.